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Lysosome function is essential in cellular homeostasis. In
addition to its recycling role, the lysosome has recently been
recognized as a cellular signaling hub. We have shown in mam-
mary epithelial cells, both in vivo and in vitro, that signal trans-
ducer and activator of transcription 3 (Stat3) modulates lyso-
some biogenesis and can promote the release of lysosomal
proteases that culminates in cell death. To further investigate
the impact of Stat3 on lysosomal function, we conducted a pro-
teomic screen of changes in lysosomal membrane protein com-
ponents induced by Stat3 using an iron nanoparticle enrich-
ment strategy. Our results show that Stat3 activation not only
elevates the levels of known membrane proteins but results in
the appearance of unexpected factors, including cell surface
proteins such as annexins and flotillins. These data suggest that
Stat3 may coordinately regulate endocytosis, intracellular traf-
ficking, and lysosome biogenesis to drive lysosome-mediated
cell death in mammary epithelial cells. The methodologies
described in this study also provide significant improvements to
current techniques used for the purification and analysis of the
lysosomal proteome.
Lysosomes are intracellular organelles, so-named from the
Greekwords lysis (dissolution or destruction) and soma (body),
that were first described by Christian de Duve over half a cen-
tury ago (1). The lysosome has an essential function in the
digestion of old organelles, engulfed proteins, and microbes
that are delivered to the lysosome for degradation by auto-
phagy, endocytosis, and phagocytosis, respectively. Delivery is
mediated by kissing events between lysosomes and late endo-
somes/multivesicular bodies or by direct fusion of lysosomes
and autophagosomes (2). Lysosomes can also fuse with the
plasmamembrane tomediate repair and exocytosis (3). Subop-
timal lysosome function and reduced lysosomal clearance is
associated with aging, neurodegenerative diseases such as Alz-
heimer’s, and lysosomal storage disorders caused by deficien-
cies in lysosomal proteins or trafficking (4). The lysosomal
lumen harbors numerous acid hydrolases that digest a wide
array of cellular macromolecules and membranes with the
resulting catabolites being recycled back to the cytosol (5). Lys-
osomal proteases havemultiple additional roles, including bone
remodeling, angiogenesis, neuronal cell maintenance, cell
death, and cancer cell invasion (6).
The lysosomal proteome has been investigated using a vari-
ety of mass-spectrometry (MS)–based approaches, including
affinity purification methods that exploit the mannose 6-phos-
phatemodifications required to traffic proteins to the lysosome
(7–11). Such approaches have enabled the identification of
both known and previously uncharacterized proteins involved
in lysosome biology (8). However, sorting signals present on
lysosomal membrane proteins are less amenable to purifica-
tion, and difficulties in isolating pure populations of lysosomes
have hindered proteomic analysis of lysosomalmembrane con-
stituents. As a result, this proteome is considered relatively
incomplete (12). Traditional methods for isolating lysosomes
have relied upon density centrifugation, resulting in prepara-
tions that are commonly contaminated by other organelles of
similar density, including mitochondria and peroxisomes (8,
13–15). Protein correlation profiling can partially mitigate this
problem and provide information about the steady-state distri-
bution of proteins within organelles (16, 17). However, lyso-
somes can be highly heterogeneous in nature, and in biological
contexts where their function is impaired or altered (e.g. in lys-
osomal storage disorders) changes in lysosomal buoyant den-
sity result in their redistribution across a density gradient, thus
hampering their purification by differential centrifugation (13,
18, 19). To overcome these difficulties, we and others have uti-
lizedmagnetic iron nanoparticles to isolate lysosomes fromdif-
ferent cell types (13, 18, 20, 21). The internalization anddelivery
of nanoparticles via the endocytic pathway to lysosomes
enables their isolation by magnetic chromatography. More
recently, the utility of this method for LC-MS/MS analysis of cel-
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lular trafficking events has been demonstrated (22, 23). However,
the application of this methodology to specifically investigate
changes in the lysosomal membrane proteome in the context of
lysosomal dysfunction (including during lysosomal membrane
permeabilization (LMP))4 has yet to be explored.
Components of the lysosomal membrane fulfil a number of
crucial functions, including acidification of the lysosomal
lumen, membrane fusion with other organelles, and transport
events that facilitate the transfer of macromolecules and degra-
dation products (12, 24). Preservation of lysosomal function
requires the multicomponent vacuolar-type ATPase to main-
tain the acidic luminal pH. The role of the densely glycosylated
proteins LAMP1 and LAMP2, which constitute over 50% of the
lysosomal membrane proteins (12), is less clear. It has been
suggested that they form a glycocalyx that protects the ly-
sosomal membrane from autodigestion (12, 25). However,
other studies indicate that they are not required simply for
membrane stability (12), although glycosylation is necessary to
protect LAMP1/2 from the action of lysosomal proteases (25).
LMP, and the subsequent intracellular release of lysosomal
hydrolases such as cathepsin proteases, is widely implicated
in the initiation or enhancement of cell death programs (26).
Although cathepsin release may result in the activation of the
caspase cascade, cell death can also be initiated in a caspase-
independent manner (27) in a process termed lysosome-medi-
ated programmed cell death (28). The mechanisms driving
LMP appear to be highly cell-type– and context–dependent
and have been observed across a wide spectrum of species
includingCaenorhabditis elegans (29). In addition tomediating
cell death in pathological conditions, lysosome-mediated pro-
grammed cell death can regulate cell death under physiological
conditions, such as during post-lactational regression (involu-
tion) of the mammary gland (20, 30). This complex and highly
regulated program of cell death requires Stat3 signaling that
coordinately up-regulates the lysosomal system and abrogates
expression of the endogenous cathepsin inhibitor Spi2a (30,
31). Subsequent LMP and leakage of cathepsin proteases into
the cytosol results in extensive cell death (30). More recently,
we have shown that Stat3 activation mediates the uptake of
milk-fat globules that are delivered to large lysosomal vesicles
for degradation (20). The resulting high local concentrations of
free fatty acids within these structures lead to increased mem-
brane permeability, cathepsin leakage, and cell death (20).
These events can be modeled in vitro using oncostatin M
(OSM) stimulation of Stat3 activity in the normal mouse mam-
mary epithelial EpH4 cell line (20, 30). It is unclear, however,
whether Stat3 signaling has a direct, modulatory effect on the
lysosomal membrane proteome. Here, we utilized LC-MS/MS
analysis of lysosomes isolated from OSM-stimulated or un-
stimulated EpH4 cells to address this question and to pro-
vide further insights into the protein composition of lyso-
somal membranes during lysosome-mediated programmed
cell death.
Results
Iron nanoparticles facilitate the isolation of highly pure
lysosomal preparations from EpH4 cells for
mass-spectrometry analysis
Previously, we developed a magnetic iron nanoparticle pro-
tocol to isolate functional lysosomes for membrane permeabil-
ity studies(20). To investigate the suitability of these prepara-
tions for downstream MS analysis, we sought to further
characterize the lysosomes isolated using this method. By
transmission electron microscopy (TEM) we observed that
fluid phase uptake of nanoparticles by EpH4 cells led to the
specific loading of degradative lysosomal vacuoles (Fig. 1A).
Importantly, these particles were nontoxic, and cytotoxicity
was observed only in the presence of hydrogen peroxide (Fig.
1B), likely a consequence of reactive free radicals generated by
the Fenton reaction (32). Using iron nanoparticles, we were
able to enrich and isolate EpH4 lysosomes with relative ease
(Fig. 1C). The lysosomal identity of the isolated organelles was
confirmed by TEM analysis, which showed the presence of vac-
uolar structures containing magnetic nanoparticles (Fig. 1D,
upper panel). Furthermore, negative staining of samples also
revealed the presence of iron-containing membrane-bound
organelles having a size and morphology consistent with lyso-
somes (Fig. 1D, lower panel). Importantly, fluorescence imag-
ing and Western blot analysis of iron-labeled (Mag) prepara-
tions revealed nearly undetectable levels of mitochondrial
proteins (Fig. 1, E and F), a common contaminant of lysosomal
preparations isolated using methods such as density gradient
centrifugation. In addition, contamination by other organelles,
including endocytic vesicles and endoplasmic reticulum (ER),
was minimal (Fig. 1F), demonstrating the effectiveness of this
method for yielding highly pure lysosomal preparations.
To further enrich for lysosomal membrane proteins and to
reduce the contribution from cargo delivered to the lysosomes
for degradation, isolated preparations were subjected to hypo-
tonic lysis and centrifugation to separate lysosomal mem-
branes. Using this method, the lysosomal membrane protein
LAMP2 could be specifically detected in lysosomal membrane
(LM) fractions (Fig. 2A). However, the lysosomal hydrolase
cathepsin L (Ctsl) was detected at comparable levels in both the
LM and the soluble compartments (LC, lysosomal content) of
purified lysosomes (Fig. 2, A and B), suggesting that not all
organelles were successfully ruptured. To overcome this poten-
tial issue, preparationswere subsequently subjected to repeated
cycles of freeze-thawing. This optimization improved the
enrichment of cathepsin activity in the soluble fraction (Fig.
2C), indicating the enhanced disruption of lysosomes. We also
assessed the activity of -glucuronidase, a lysosomal enzyme
that is predominately localized in the lysosomal matrix and has
minimal adherence to membranes (33), to more definitively
assess the degree of lysosomal membrane disruption. As
expected, -glucuronidase activity in the soluble fraction was
higher than in the membrane preparations and was markedly
increased by freeze-thawing (Fig. 2D). Therefore, hypotonic
4 The abbreviations used are: LMP, lysosomal membrane permeabilization;
LM, lysosomalmembrane; LC, lysosomal content; OSM, oncostatinM; TEM,
transmission electron microscopy; ER, endoplasmic reticulum; KEGG,
Kyoto Encyclopedia of Genes andGenomes; GO, gene ontology; FDR, false
discovery rate; PNGase, peptide-N-glycosidase; PNS, post-nuclear super-
natant; SN, supernatant; Z, benzyloxycarbonyl; AMC, 7-amino-4-methyl-
coumarin; emPAI, exponentially modified protein abundance index.
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lysis of isolated lysosomes, combinedwith freeze fracture, facil-
itated the enrichment of lysosomal membranes for down-
streamMS analysis.
Mass-spectrometry analysis of EpH4 cell lysosomalmembrane
preparations isolated using iron nanoparticles
To further validate and assess the efficacy of the optimized
lysosomal membrane isolation procedure prior to undertaking
large-scale experiments, a pilot preparation was submitted for
LC-MS/MS analysis. Here, 1664 proteins were identified byMS
(Table S1A), which notably included numerous known lyso-
somal membrane proteins (8, 34) (Table 1), thus validating the
utility of our lysosomal purification method for downstream
proteomic analysis. Proteins that were also identified in the
corresponding unlabeled (no magnetic particles) control sam-
ple (327 proteins, Table S1B) and that did not belong to the
Stat3 alters proteins in the lysosomalmembrane
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endocytic-lysosomal pathway were removed from this list. Fur-
thermore, published common contaminants of MS experi-
ments (35), such as heat-shock proteins, keratins, tubulins,
actins, elongation factors, histones, and ribosomal and ribonu-
cleoproteins, were also removed. This resulted in a subset of
1295 proteins (Table S2). To obtain a functional overview of the
proteins identified, the Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway and gene ontology (GO) enrich-
ment analysis was undertaken using the online gene list enrich-
ment analysis tool Enrichr (36, 37) (http://amp.pharm.mssm.
edu/Enrichr/).5 Analysis of the KEGG pathway annotations
associated with this subset revealed a significant enrichment in
the proteins involved in the lysosomal and related pathways,
including neurodegenerative diseases allied with lysosomal
dysfunction (Fig. S1A and Table S3A). Furthermore, GO term
distribution analysis for the cellular component confirmed the
lysosomal and vesicular membrane localization of the identi-
fied proteins (Fig. S1B and Table S3B). Functional analysis also
revealed the enrichment of mitochondrial membrane proteins
involved in oxidative phosphorylation (Fig. S1A and B). This
suggests that lysosomal preparations isolated using iron nano-
particles may contain a degree of mitochondrial contamination
that is undetectable by Western blotting or MitoTrackerTM
analysis (e.g. Fig. 1, E and F). However, it is important to note
that this contamination may also reflect the delivery of dam-
aged mitochondria to the lysosome for turnover during
mitophagy (20, 38) or the remnants of lysosomal-mitochon-
drial contact sites (39, 40).
OncostatinM stimulates vesicle biogenesis in EpH4 cells
We have shown previously that stimulation of EpH4 mam-
mary epithelial cells by OSM leads to LMP (30). OSM-induced
Stat3 phosphorylation in EpH4 cells resulted in the increased
expression of multiple target genes, including the phosphatidy-
linositol 3-kinase subunits p55 and p50 (41) and the lyso-
5 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure 1. Iron nanoparticle-mediated isolation of EpH4 cell lysosomes. A, TEM images of EpH4 cells showing iron nanoparticles residing in degradative
lysosomal vacuoles (arrowheads) or in lysosomal vacuoles devoid of degradative material (arrows). Scale bars: 500 nm. B, bright-field microscopy and quanti-
fication of iron nanoparticle–induced cell death of EpH4 cells observed solely in the presence of hydrogen peroxide (H2O2). EpH4 cells were treatedwith H2O2
for 19 h. Scale bars: 25m. C, schematic of themagnetic iron nanoparticle lysosomal purification protocol. Adapted from Sargeant et al. (20).D, TEM images of
lysosomes (top panel) and negatively stained lysosomes (bottom panel) isolated using themagnetic iron nanoparticle purification protocol. Arrowheadsmark
areas containing iron nanoparticles. Arrows indicate unidentifiablemembranous fragments, whichmay be endolysosomal tubules or remnants from the ER or
Golgi apparatus. Scale bars: 500nm. E, isolated EpH4 lysosomes arepredominantly clear ofmitochondria. EpH4 cellswere labeledwith 10 kDa FITC-dextran (2.5
mg/ml (green)) with (Mag) orwithout (Mag) iron nanoparticle–containingmedia for 2 h and subsequently stainedwithMitoTrackerTM (500 nm (red)) for 30
min prior to isolation. Representative images of the PNS, post-magnetic SN, andmagnetic lysosomal pellet (LP) of the two conditions are shown. Scale bar: 10
m. F, isolated EpH4 lysosomes are highly pure with undetectable contamination from other organelles as observed by immunoblotting. N, nuclear lysate.
Organelle marker proteins: LAMP2, lysosomes; ERp57, endoplasmic reticulum; GAPDH, cytoplasm; Rab5, early endosomes; Cox IV, mitochondria; Histone H3,
nucleus.
Figure2.Membrane fractionationof isolatedEpH4 lysosomes.A, hypotonic lysis of lysosomes isolated fromEpH4cells using ironnanoparticles to separate
the LM from the LC. LAMP2 immunoblotting shows its enrichment in the LM fraction. Ctsl, cathepsin L (sc, single chain: dc, double chain); SN, post-magnetic
supernatant. B, cathepsin activity in EpH4 lysosomes isolated using iron nanoparticles and extracted using TX-100 (TX, total lysosomal content) or by
hypotonic lysis and fractionation (LM, membrane fractions; LC, matrix) compared with unlabeled control samples (TX, LM, and LC). C and D, freeze-
thawing of lysosomes improved lysosomemembrane separation from the lysosomal matrix. Cathepsin (C) and -glucuronidase activity (D) in the LC fraction
is shown as -fold of LM. AFU, arbitrary fluorescence units.
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somal protease cathepsin B (Fig. 3A, Ctsb), alongside increased
vacuole formation (Fig. 3B) (20), which appeared to be degra-
dative in nature (Fig. 3C). These structures accumulate the lyso-
somotropic dye LysoTracker Red, thus revealing their ly-
sosomal origin (Fig. 3D). Notably, the apparent size of the
lysosomal compartment is increased by OSM treatment and is
associated with a more perinuclear localization (Fig. 3D).
To further characterize Stat3-induced changes to the lyso-
somal compartment, we sought to isolate lysosomes from
OSM-stimulated EpH4 cells using the optimized magnetic
nanoparticle fractionation protocol. Western blot analysis of
the lysosomal markers LAMP2 and cathepsin L demonstrated
that this technique was also applicable to OSM-treated cells
and that the stimulation did not significantly interfere with iron
uptake (Fig. 3E). Interestingly, OSM treatment resulted in
increased LAMP2 glycosylation, as observed by the molecular
weight shift in LAMP2 onWestern blot analysis (Fig. 3E). Pro-
longed OSM treatment resulted in cell death (Fig. 3B) (30),
leading to a reduction in protein yields as compared with con-
trol-treated EpH4 cells (Fig. 3E, PNS lane). Nevertheless, OSM-
mediated induction of cathepsin L expression corresponded to
an approximately 16-fold increase in enzyme activity inside the
lysosomal matrix (Fig. 3F, LC).
OSM-induced changes to the EpH4 lysosomal proteome
Having established that lysosomes from OSM-treated EpH4
cells could be isolated using our purification method, we then
investigated the effect of Stat3 activation on the lysosomal pro-
teome. Lysosomemembrane preparations from three indepen-
dent biological replicates of vehicle andOSM-treated cells were
submitted for LC-MS/MS analysis. For each replicate a corre-
sponding unlabeled (no iron particles) control was also
included to filter out nonspecific contaminants. Prior to MS
analysis, lysosomes purified from OSM and control (vehicle)-
treated cells were assessed for lysosomal membrane enrich-
ment (Fig. 4A) and purity (Fig. 4B). Importantly, Western blot
analysis of iron-labeled LM preparations revealed nearly unde-
tectable levels of contamination by other organelles (Fig. 4B).
However, we observed low levels of COX IV, a mitochondrial
marker, in one of the three replicates (Fig. 4B), which was
derived either from contaminating mitochondria or from lyso-
somal mitophagic cargo. A label-free, exponentially modified
protein abundance index (emPAI)-based semiquantitative pro-
teomics approach was used to profile OSM-induced changes in
protein abundance (see “Experimental procedures”). Raw data
for all samples are shown in Table S4. MS analysis of three
independent biological repeats (three OSM and corresponding
vehicle control samples) resulted in the identification of 35,076
spectra within a 1% false discovery rate (0.66% decoy FDR) and
an average spectrum identification rate of over 24% (Table S5).
Coalescence of redundant identifications from repeat and over-
lapping peptides resulted in a list of 644 unique proteins at a
probability of over 99%, which contained at least three identi-
fied peptides (established at greater than 95% probability),
within a false discovery rate of less than 5% (Fig. 4C and Tables
S4 and S6). Proteins that were also identified in the correspond-
ing unlabeled (no magnetic particles) control sample for each
independent replicate, not belonging to the endocytic-lyso-
somal pathway, were removed from this list. In addition, known
common contaminants (35) were deleted as described above.
Exceptions to this rule were considered if their representations
changed significantly withOSM treatment, e.g. keratin 8, which
is a definitive marker of luminal mammary epithelial cells. This
Table 1
Known lysosomal membrane proteins identified in lysosomal preparations isolated using iron nanoparticles
Published lysosomal membrane proteins that were identified by mass spectrometry in a preliminary experiment to validate the iron nanoparticle–mediated lysosomal
isolation protocol (associated with Table S1).
Protein Reference Protein Reference
H-ATPase V1 subunit A (34) LIMP2 (66)
H-ATPase V1 subunit B2 (34) Sialin (67)
H-ATPase Vo 116-kDa subunit a isoform 1 (34) CLC-7 (68)
H-ATPase Vo subunit d (34) ATPase 13A2 (69)
H-ATPase V1 56/58-kDa subunit B1 (34) Mucolipin-1 (70)
H-ATPase V1 subunit H splice isoform 1 (34) rPHT2 (71)
H-ATPase V1 subunit C (34) GLUT-8 (72)
H-ATPase V1 subunit E (34) Equilibrative nucleoside transporter 3 (73)
H-ATPase Vo 116-kDa subunit a isoform 2 (34) Natural resistance-associated macrophage protein 2 (74)
H-ATPase V1 subunit D (34) Zinc transporter 2 (75)
H-ATPase V1 subunit G1 (34) ATP-binding cassette subfamily A member 3 (76)
S1 accessory proteins (Ac45) (34) ATP-binding cassette subfamily B member 9 (77)
H-ATPase Vo 16-kDa proteolipid subunit c (34) Probable lysosomal cobalamin transport (78)
Glucosylceramidase (34) Major facilitator superfamily domain--containing protein 8 (79)
Arf-like 10C (Arl8B) (34) Heparan--glucosaminide N-acetyltransferase (80)
Flotillin 1 (34) Signal peptide peptidase-like 2A (81)
Arf-like 10B (Arl8A) (34) Nicastrin (82)
Lysosomal -glucosidase (34) Presenilin1 (82)
SLC29A3 nucleoside transporter (34) Transmembrane protein 55A (83)
Chloride channel 5, CLC5 (34) Transmembrane protein 55B (83)
MLN64 N-terminal domain homolog (34) Vesicle-associated membrane protein 7 (84)
Phospholipase D1 isoform, PLD1A (34) Transmembrane protein 192 (34)
Endothelin-converting enzyme 1 isoform B (34) Lysosomal protein NCU-G1 (85)
C18orf8 protein, Mic1 (34) Transmembrane protein 63A (8)
SID1 transmembrane protein, SIDT2 (34) Niemann-Pick C1 protein (86)
GPR137 protein (34) Niemann-Pick C2 protein (87)
LAMP1 (88) Osteopetrosis-associated transmembrane protein 1 (68)
LAMP2 (88)
CD63/LIMP1 (89)
Stat3 alters proteins in the lysosomalmembrane
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resulted in a subset of 447 proteins (Fig. 4C and Table S7); 320
of these 447 proteins were identified in at least five of the six
preparations (3 vehicle-treated and 3 OSM-treated sam-
ples) (Table S8). Pathway analysis (KEGG (37)) on this more
stringent subset validated the lysosomal nature of the proteins
identified, which included numerous known lysosomal compo-
Stat3 alters proteins in the lysosomalmembrane
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nents (Fig. 4D and Table S9A). A significant enrichment was
also observed for components involved in phagocytosis. This
was not unexpected given that the ultimate destination of pha-
gosomes is the lysosomal compartment. Moreover, GO term
distribution analysis for the cellular component confirmed the
lysosomal and vesicular membrane localization of the identi-
fied proteins (Fig. 4E and Table S9B). In vehicle- and OSM-
treated samples, 3 and 21 proteins, respectively, were identified
exclusively (Fig. 4C and Table 2).
Although the lysosomal nature of most proteins (408 of 447)
remained similar between vehicle- and OSM-treated prepara-
tions, a subset of 39 proteins ( 9%) showed more significant
changes in abundance between the different conditions (Fig.
4C, Table 3, and Table S10). A striking decrease in lysosomal
enzymes, including galactocerebrosidase, -hexosaminidase,
and lysosomal -mannosidase, was observed with OSM treat-
ment (Fig. 4F, Table 3, and Table S10), suggesting either that
Stat3 affects the distribution of these enzymes or, more likely,
that these have been depleted from the lysosomes as a result of
LMP. OSM stimulation also resulted in the increased represen-
tation of cell surface proteins and cytoskeletal components
such as integrins, annexins, and flotillins (Fig. 4F, Table 3, and
Table S10). Interestingly, this suggests that endocytosis, and the
subsequent transport and localization of cargo into the lyso-
somal compartment, is stimulated upon Stat3 activation, sup-
porting our previous observations in vivo (20).
To validate these results, immunoblot analysis of lysosomal
protein preparations, used for theMS analysis, was undertaken.
Flotillins are interesting candidates, as they are involved in
endocytosis and membrane trafficking and form clusters in
plasma membrane lipid rafts (42, 43). Flotillin 1 was signifi-
cantly enriched in lysosomes isolated from OSM-stimulated
cells (Fig. 4F and Table 3), and although not statistically signif-
icant, the related protein, flotillin 2, also showed an increased
representation in OSM-treated lysosomes (Fig. 4F). Although
flotillin 1 and flotillin 2 were undetectable in lysosomal prepa-
rations from untreated EpH4 cells, OSM stimulation of Stat3
activity resulted in the appearance of considerable amounts of
both of these proteins in the lysosomal compartment (Fig. 5A).
This was not surprising, as flotillin 2 has been observed previ-
ously to traffic from the plasma membrane to endosomes (42,
43), which may subsequently fuse with lysosomal structures.
Further support for the endocytosis of flotillins in response to
Stat3 is provided by the observation that OSM treatment of
EpH4 cells for only 24 h resulted in increased internalization of
flotillin 2 puncta in EpH4 cells (Fig. S2).
Annexins A1, A6, and A11 were also enriched in lysosomal
fractions following OSM stimulation (Table 3). Our previous
microarray data of a mammary gland developmental cycle (44)
revealed the down-regulation of these annexins during lac-
tation (Fig. S3). Interestingly, although expression levels of
annexin A6 remained fairly consistent across all lactation and
involution timepoints, a substantial increase in the expression
of annexins A11 and A1 was observed during involution (Fig.
S3). This pattern is similar to that of flotillins 1 and 2 (Fig. 5B),
suggesting that all of these membrane proteins may play signif-
icant roles in the regression of the mammary gland. Indeed,
mRNA expression of both Flot1 and Flot2 is down-regulated
2-fold in the mammary glands of Stat3 knockout mice at 24 h
involution (Table S11). In addition, the glutathione S-transfer-
aseMgst1was also identified in lysosomal preparations purified
from OSM-treated EpH4 cells (Tables 2 and 3). Mgst1 is a
detoxifying enzyme and therefore may be up-regulated in
response to iron nanoparticle uptake. However, as it was pres-
ent only in theOSM-treated samples, it is tempting to speculate
that it could be induced to protect against the effects of LMP.
Indeed, an increase inMgst1 and the related proteinMgst3 was
observed during mammary gland involution (Fig. S3), suggest-
ing that they may possess important functions during lyso-
some-mediated cell death in vivo.
Although a significant number of known lysosomal mem-
brane proteins were identified byMS analysis, the relative yield
of some peptides (including from abundant proteins such as
LAMP1 and LAMP2) was lower than expected, similar to what
was observed in previous studies (34). One possible explanation
is that the heavily glycosylated nature of many lysosomal mem-
brane proteins may interfere with MS analysis. To address this
possibility, lysosomal membrane samples were deglycosylated
using peptide-N-glycosidase F (PNGase F) prior to proteomic
analysis. PNGase F is an amidase that cleaves between the
innermost N-acetylglucosamine (GlcNAc) and asparagine res-
idues of oligosaccharides from N-linked glycoproteins (45).
PNGase F treatment resulted in the efficient removal of
N-linked glycans from LAMP2 proteins, as shown by the
appearance of a sharp band at30 kDa by immunoblot analysis
(Fig. S4). To determine whether the representation of heavi-
ly glycosylated proteins is improved after deglycosylation,
PNGase F enzyme–treated and untreated lysosomalmembrane
samples were analyzed by LC-MS/MS.Western blot analysis of
various organelle markers was performed to check the purity of
the preparations as described previously (Fig. S4). 955 and 718
proteins were identified in control and enzyme-treated lyso-
somal membrane samples, respectively (Table S12). Compara-
tive analysis of heavily glycosylated proteins, such as LAMP1,
LAMP2, LIMP2, and CD63/LIMP1, revealed that deglycosyla-
tion increased the number of unique peptide sequences identi-
fied for these proteins, vastly improving their representation
and identification by LC-MS/MS (Table S13). Of note, degly-
cosylation did not appear to have a detrimental impact on the
identification of lysosomalmembrane proteins, with themajor-
ity higher ranked in PNGase F-treated samples (Table S13).
Therefore, future proteomic experiments investigating lyso-
somal membrane composition will likely benefit from utilizing
deglycosylating approaches prior to LC-MS/MS.
Figure 3. OSM induces vesicular biogenesis in EpH4 cells. A, immunoblot showingOSM-induced expression of p55/p50 and cathepsin B (Ctsb; sc, single
chain) downstream of activated Stat3 signaling in EpH4 cells. B, bright-field microscopy showing OSM-induced vacuolization in EpH4 cells treated for 72 h.
Scale bars: 25 m. C, TEM images showing an increased number of degradative vesicles after 72 h of OSM stimulation. Scale bars: 500 nm. D, fluorescence
microscopyof LysoTrackeraccumulation in cells treatedwithOSMfor72h. Scale bars: 20m.E,Westernblot analysis of LAMP2andcathepsin L in fractionated
lysosomes isolated from vehicle and OSM stimulated (72 h) cells using iron nanoparticles. sc Ctsl, single-chain cathepsin L; dc Ctsl, heavy chain of the double-
chain form of cathepsin L. F, graph showing increased cathepsin activity in LC and LM fractions from OSM-stimulated cells. AFU, arbitrary fluorescence units.
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Stat3-mediated regulation of the lysosomal compartment
To investigate the biological relevance of OSM-induced
changes to the lysosomal compartment, we used CRISPR/Cas9
technology to ablate Stat3 in EpH4 cells. Mass-spectrometry
analysis revealed that the lysosomalmembrane protein LAMP2
is up-regulated in response toOSMstimulation of Stat3 activity
(Fig. 4F and Table 3). Indeed, LAMP2 and LAMP1 immuno-
staining in EpH4 cells clearly showed enhanced lysosomal bio-
genesis in response to OSM, with lysosomes becoming increas-
ingly perinuclear in distribution (Fig. 5C). Surprisingly, we
found that the deletion of Stat3 abrogated the increase in the
apparent molecular weight of LAMP1 and LAMP2 that occurs
in response to OSM treatment (Figs. 3E and 5D), suggesting a
role for this post-translation modification of LAMP1 and
LAMP2 in lysosome function. Importantly, a similar shift in
mobility is observed during involution of the mouse mammary
gland (30) and is likely due to a change in glycosylation. Stat3
also up-regulates the expression of the lysosomal protease
cathepsin B and the endolysosomal membrane protein CD63
(Fig. 5D and Table S11). At a transcriptional level, both CD63
and Lamp2mRNAs are down-regulated during lactation and rise
sharply during involution (Fig. 5E). Together, these data suggest
thatStat3directlymodulates lysosomalmembraneconstituents to
induce lysosomal leakiness and consequent cell death.
Discussion
The lysosome is enjoying a renaissance as a signaling center
and monitor of cellular nutritional status (46). Although
microarray studies are very useful in highlighting transcrip-
tional changes in response to transcription factors such as
Stat3, they are of little value in determining the functional
downstream consequences of altered protein expression. Hav-
ing determined a role for Stat3 in lysosomal function, we aimed
to characterize this at the level of the lysosomal membrane
proteome to shed further light on the mechanism of LMP in
mammary epithelial cells.
In the past decade, an increased knowledge of the lysosomal
proteome has been acquired through the application of MS (8,
14, 22, 34). However, although numerous lysosomalmembrane
proteins have thus far been identified using density centrifuga-
tion (14, 34), these data do not fully correlate with the plethora
of known and crucial functions of the lysosomalmembrane and
its constituent proteins and enzymes. This failure to detect all
lysosomalmembrane proteins, coupledwith the contamination
inherent in lysosome enrichment approaches used to date,
prompted us to develop an alternative method to enrich lyso-
somal membrane proteins. To circumvent alterations in the
size or buoyant density of lysosomes in response to changes in
cellular status, we utilized a different approach that is indepen-
dent of these features. Labeling and subsequent isolation of
lysosomes by uptake of magnetic nanoparticles resulted in
highly pure lysosomal membrane preparations being obtained.
Although proteins that reside in other organelles were not
detected by immunoblotting and MitoTrackerTM analysis, a
number of mitochondrial and other organellar proteins were
detected by MS. This could be due to contamination, but we
suggest that it is more likely the consequence of autophagy,
which we have shown previously to be induced in EpH4 cells,
particularly in response to OSM (38). Indeed, we observed a
considerable number of degradative structures present even in
control, non-OSM–stimulated cells (Fig. 3) (20). Functional
analysis of our MS data corroborated the lysosomal nature of
the samples and provided valuable insights into membrane
trafficking events as well as lysosomal function. Importantly,
although heavily glycosylated proteins such as LAMP1,
LAMP2, CD63/LIMP1, and LIMP2 were detected, they were
relatively under-represented. This is likely due to glycosylation-
mediated changes in mass and therefore the time of flight,
which has an impact on the resolution of the peptide spectrum
Figure 4. OSM-induced changes in the lysosomal proteome of EpH4 cells. A, Western blot analysis of LAMP2 and cathepsin L in fractionated lysosomes
isolated from vehicle and OSM-stimulated (72 h) cells and submitted for MS analysis. A representative blot from three independent experiments is presented.
sc Ctsl, single-chain cathepsin L; hc Ctsl, heavy chain of the double-chain form of cathepsin L. B, immunoblotting for organelle marker proteins in lysosomal
preparations isolated from control and OSM-stimulated EpH4 cells: ERp57, endoplasmic reticulum; GAPDH, cytoplasm; Rab5, early endosomes; Cox IV, mito-
chondria; Histone H3, nucleus. A representative blot from three independent experiments is presented. For Cox IV immunoblotting, blots from two different
replicates are shown, revealing slight contamination in one replicate. C, analysis pipeline ofmass spectrometry results obtained from lysosomes isolated from
vehicle and OSM (72 h)-treated EpH4 cells. Three independent biological repeats were undertaken per condition, and each replicate included an unlabeled
control samples (nine preparations in total). D, significantly enriched KEGG (37) pathways derived from MS analysis of EpH4 lysosomal preparations isolated
using iron nanoparticles. E, significant GO annotations of proteins according to cellular component, derived from mass-spectrometry analysis of EpH4
lysosomal preparations isolated using iron nanoparticles. For inclusion in the analysis undertaken inD and E, proteins were required to be identified in at least
five of six independent runs (3 vehicle, 3 OSM). F, volcano plot showing the -fold change in emPAI values induced by OSM stimulation. Proteins that were
significantly changed by OSM treatment are shown in green (t test, p 0.05).
Table 2
Proteins identified by MS analysis in control (vehicle) or OSM-treated
lysosomal preparations only
These data are associated with Fig. 4 and Tables S4, S6, and S7.
Accession
number (UniProt)
Gene
symbol Protein name
Vehicle only
Q8VDV8 Mitd1 MIT domain–containing protein 1
Q9WVE8 Pacsin2 Protein kinase C and casein kinase substrate
in neurons protein 2
Q8BHL4 Gprc5a Retinoic acid–induced protein 3
OSM only
Q80X90 Flnb Filamin-B
Q9EPR5 Sorcs2 VPS10 domain–containing receptor SorCS2
Q8BKG3 Ptk7 Inactive tyrosine-protein kinase 7
P40124 Cap1 Adenylyl cyclase–associated protein 1
Q91V01 Lpcat3 Lysophospholipid acyltransferase 5
P48678 Lmna Prelamin-A/C
Q61738 Itga7 Integrin -7
Q91V92 Acly ATP-citrate synthase
Q91VS7 Mgst1 Microsomal glutathione S-transferase 1
Q8BU30 Iars Isoleucine–tRNA ligase, cytoplasmic
O70309 Itgb5 Integrin -5
Q80VQ0 Aldh3b1 Aldehyde dehydrogenase family 3 member B1
P35821 Ptpn1 Tyrosine-protein phosphatase non-receptor type 1
O70133 Dhx9 ATP-dependent RNA helicase A
Q9DBG3 Ap2b1 AP-2 complex subunit 
P14901 Hmox1 Heme oxygenase 1
Q6P9J9 Ano6 Anoctamin-6
Q8BTM8 Flna Filamin-A
Q61739 Itga6 Integrin -6
P97384 Anxa11 Annexin A11
Q62261 Sptbn1 Spectrin -chain, non-erythrocytic 1
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acquired (47). We show here that prior deglycosylation treat-
ment considerably improves the representation of these pro-
teins (Table S13) and suggest that future proteomics experi-
ments should consider utilizing this approach.
We analyzed the lysosomal proteome in both intact and leaky
lysosomes, the latter treated with OSM to induce Stat3 activa-
tion and subsequent LMP. Interestingly, OSM treatment
resulted in a clear loss of lysosomal enzymes, probably as a
consequence of LMP and leakage of proteases to the cytosol. In
contrast, OSM-induced elevated cargo levels, probably as a
consequence of the increased endocytosis and down-regulation
of cell surface receptors and adhesion complexes that are sub-
sequently delivered to the lysosome. Observed changes in cyto-
skeletal proteins may be relevant to lysosomal localization,
which in turn influences internal pH (48) with possible effects
on protease functions and LMP. Intriguingly, in support of this
notion, OSM stimulation resulted in increased perinuclear dis-
tribution of lysosomes in EpH4 cells (Figs. 3D and 5C).
Interesting candidates for further characterization include
flotillins 1 and 2. Data from this study show that OSM treat-
ment causes trafficking of these proteins to the degradative
endolysosomal pathway. Flotillins (or reggies) form clusters in
lipid rafts and have been shown to regulate trafficking of5 and
1 integrins and thus the formation of focal adhesions (49).We
speculate that OSM treatment would induce cells to detach,
with consequent turnover of focal adhesions and trafficking of
integrins to the lysosome. Indeed, mRNA expression of both
Flot1 and Flot2 is down-regulated 2-fold in the mammary
glands of Stat3 knockout mice at 24 h involution (Table S11).
Their roles in regulatingmammary cell death during involution
in vivo, therefore, warrants further investigation.
Other interesting candidates for validation include annexins
A1 (Anxa1), A6 (Anxa6), and A11 (Anxa11). Annexins are a
family of highly conserved proteins that bind to negatively
charged phospholipids and membranes in a calcium-depen-
dent manner (50). Studies in annexin knockout mice suggest
that annexin A1 fulfils multiple roles, including trafficking at
the plasma membrane and in the endocytic compartment (50).
Annexin A6 is also involved inmembrane organization and the
distribution of proteins in rafts (51). Recently, annexin A11 has
been shown to physically associate with a component of the
coat protein complex II (COPII) machinery that is associated
with the ER and controls the transport of transmembrane car-
goes from the ER to the Golgi (52). Thus, the changes we
observed in the lysosomal levels of these three annexins could
Table 3
Proteins represented differentially in OSM-treated lysosomal preparations
Sixteen (italic) and 23 (bold) proteins were differentially represented in control and OSM-treated samples (depicted in Fig. 4C). Many lysosomal enzymes were decreased
by OSM, whereas the lysosomal localization of cell surface and cytoskeletal components were increased. Proteins that were absent/nearly absent from the comparator
sample (Infinite (INF) or 0) are not plotted in Fig. 4F.
Protein name
Gene
symbol
Accession
no.
p
valuea
-Fold
changeb
MIT domain–containing protein 1 OS Mitd1 Q8VDV8 0.034 0
Epoxide hydrolase 1 OS Ephx1 Q9D379 0.015 0.06
Galactocerebrosidase OS Galc P54818 0.0021 0.09
Palmitoyl-protein thioesterase 1 OS Ppt1 O88531 0.00089 0.1
Acid ceramidase OS Asah1 Q9WV54 0.014 0.1
E3 ubiquitin-protein ligase RNF13 OS Rnf13 O54965 0.043 0.1
CD82 antigen OS Cd82 P40237 0.0091 0.2
-Hexosaminidase subunit beta OS Hexb P20060 0.022 0.2
Lysosomal -mannosidase OS Man2b1 O09159 0.014 0.3
IST1 homolog OS Ist1 Q9CX00 0.019 0.3
-Glucuronidase OS Gusb P12265 0.047 0.3
Lactadherin OS Mfge8 P21956 0.0067 0.4
Ras-related protein Rab-18 OS Rab18 P35293 0.025 0.4
Claudin-3 OS Cldn3 Q9Z0G9 0.011 0.5
Retinoid-inducible serine carboxypeptidase OS Scpep1 Q920A5 0.014 0.5
Sideroflexin-1 OS Sfxn1 Q99JR1 0.046 0.5
Lysosome-associated membrane glycoprotein 2 OS Lamp2 P17047 0.003 1.5
Integrin -1 OS Itgb1 P09055 0.017 2.2
Monocarboxylate transporter 1 OS Slc16a1 P53986 0.022 2.5
Basigin OS Bsg P18572 0.0017 3.1
Importin subunit -1 OS Kpnb1 P70168 0.0026 3.5
Annexin A1 OS Anxa1 P10107 0.0051 4.3
ADP-ribosyl cyclase 2 OS Bst1 Q64277 0.022 4.5
Catenin -1 OS Ctnnd1 P30999 0.013 4.9
Annexin A6 OS Anxa6 P14824 0.0025 5.8
Junction plakoglobin OS Jup Q02257 0.023 8.1
Talin-1 OS Tln1 P26039 0.032 8.5
Flotillin-1 OS Flot1 O08917 0.036 8.7
Keratin, type II cytoskeletal 8 OS Krt8 P11679 0.0016 9.3
T-complex protein 1 subunit OS Cct2 P80314 0.018 9.6
Vinculin OS Vcl Q64727 0.027 12
Protein-glutamine -glutamyltransferase 2 OS Tgm2 P21981 0.044 14
Microsomal glutathione S-transferase 1 OS Mgst1 Q91VS7 0.0049 INF
Filamin-A OS Flna Q8BTM8 0.0056 INF
Integrin -6 OS Itga6 Q61739 0.027 INF
Annexin A11 OS Anxa11 P97384 0.028 INF
Filamin-B OS Flnb Q80X90 0.041 INF
Integrin -7 OS Itga7 Q61738 0.041 INF
Inactive tyrosine-protein kinase 7 OS Ptk7 Q8BKG3 0.042 INF
a Determined by t test.
bOSM/vehicle as measured by emPAI.
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be a reflection of the elevated vesicle formation induced by
OSM.
Finally, using CRISPR/Cas9 technology to ablate Stat3 in
EpH4 cells, we reveal a direct role for Stat3 signaling in the
regulation of lysosomal proteins such as cathepsin B, CD63,
LAMP1, and LAMP2. Surprisingly, we show that Stat3 regu-
lates the glycosylation status of LAMP1 and LAMP2 in
response to OSM treatment in EpH4 cells (Fig. 5D), mimicking
that observed during involution of the mouse mammary gland
(30). An intriguing possibility is that Stat3 could induce the
Stat3 alters proteins in the lysosomalmembrane
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expression of fucosyltransferases in mammary epithelial cells,
as LIF/Stat3 has been shown to regulate expression of 1,2-
fucosyltransferases FUT1 and FUT2, which transfer fucoses
onto the terminal galactose of N-acetyllactosamine (53). It has
been shown recently that FUT1 regulates the subcellular local-
ization of lysosomes, with FUT1 knockdown inducing perinu-
clear accumulation (54) similar to that observed upon OSM
stimulation (Figs. 3D and 5C). Together, our data suggest that
Stat3 activation induces the endocytosis of plasma membrane
constituents (including flotillins and annexins) consequently
resulting in a dramatic increase in endolysosomal trafficking
and the subsequent enhancement of the lysosomal system.
In summary, this study has refined the utility of magnetic
iron nanoparticles for the isolation of highly pure lysosomal
membrane preparations for downstream proteomic analysis.
Notably, this method can be applied to the purification of leaky
lysosomes undergoing membrane permeabilization, revealing
valuable insights into the cellular trafficking events that may
contribute to Stat3-mediated cell death. Vacuolization is impli-
cated in driving cell death in a variety of organisms, including
plant (55) andDictyosteliumdiscoideum (56) cells. Intriguingly,
an activated form of the H-Ras oncoprotein was recently
reported to induce extensive vacuolization and subsequent cell
death in cultured cancer cells (57). Thus, our method may be
utilized more widely to investigate the lysosomal proteome in
contexts associated with lysosomal perturbations, such as can-
cer, neurodegenerative diseases, and lysosomal storage disor-
ders. An improved understanding of the mechanisms driving
lysosomalmembrane permeabilization is pivotal for developing
new and effective therapies against the many disorders associ-
ated with aberrant lysosomal function.
Experimental procedures
Cell culture
EpH4 cells (58) were maintained in DMEM (Life Technolo-
gies) supplemented with 10% FCS (Sigma) at 37 °C in a humid-
ified atmosphere of 5% CO2. For OSM stimulation, cells were
stimulated at 50% confluency with a final concentration of 25
ngml1 recombinantmouse oncostatinM (495-MO,R&DSys-
tems) or carrier (0.0001%BSA in PBS) inDMEMsupplemented
with 1% FCS. Medium was renewed with fresh OSM (in 1%
FCS/DMEM) after 48 h. Cells were harvested 72 h after stimu-
lation. Cytotoxicity was assessed by trypan blue exclusion.
CRISPR/Cas9 Stat3 KO cell line generation
Two SpCas9 guide sequences targeting themouse Stat3 gene
were designed using the sgRNA scoring algorithm from
Doench et al. (59). These were cloned into the lentiCRISPRv2
plasmid, lentivirus was produced, and EpH4 cells were trans-
duced and selected using puromycin according to previously
described protocols (60, 61). Using different guide sequences,
two independent Stat3KO lineswere derived andmaintained in
the pooled state (as single-cell cloning of EpH4 cells would
likely lead to clonal artifacts). Stat3KO1 was created from
virus expressing the guide sequence 5-GTACAGCGACAG-
CTTCCCCA-3 and Stat3KO2 from virus expressing the
guide sequence 5-GGAACTGCCGCAGCTCCATG-3. As
these two lines use different guide sequences, they act as off-
target controls for one another, and so any phenotypes
observed can be attributed to the loss of Stat3. Deletion of Stat3
was confirmed by TIDE analysis (62) andWestern blotting. To
further control for any effects of lentiviral transduction and
SpCas9 expression, virus expressing a “scrambled” guide (5-
AAATTAAATTTAATTTAAAG-3) that does not target
any mouse coding sequences was also used.
Ferrofluid labeling and purification of lysosomes
Lysosomes from EpH4 cells were purified using magnetic
iron nanoparticles (EMG-508, Ferrotec) as described previ-
ously (20). Briefly, EpH4 cellswere seeded at a density of 3 106
or 1  106 for OSM stimulation in 15-cm tissue culture plates
(catalog no. 168381, Nunc). The following day, or after 48 h
of OSM stimulation, cells were labeled for 4 h in iron
nanoparticle–containing media (EMG series 508, FerroTec,
1:100) followedby a 20-h chase period in cleanmedium (includ-
ing fresh OSM in the case of stimulation experiments). Cells
were then scraped in PBS and pelleted in a tabletop centrifuge
(300 rpm at 4 °C for 3 min), and the pellet was homogenized in
a tight-fitting hand-held homogenizer (5 strokes) in 700 l of
subcellular fractionation buffer (20 mM HEPES-KOH, 250 mM
sucrose, 10 mM KCl, 1.5 mMMgCl2, 1 mM EDTA, 1 mM EGTA,
8 mM dithiothreitol, and Complete protease inhibitor (Roche)
at pH 7.5). The homogenate was spun at 750 g (3500 rpm at
4 °C for 10 min) to remove nuclei and other debris followed by
a second 750 g spin to ensure complete removal of contami-
nating heavy membranes. The resulting supernatant (post-nu-
clear supernatant (PNS)) was transferred into a clean tube,
loaded onto a magnetic rack, and incubated for 1 h at 4 °C on a
rocker. A 50-l sample of PNS was retained for analysis. Fol-
lowing incubation, tubes were left on the magnet, and the
supernatant (SN) was removed (retaining 50 l for analysis).
Tubeswerewashed three timeswith 1ml of subcellular fraction
buffer. Following the addition of the last wash, tubes were
removed from the magnet and spun at 12,000 rpm (13,800 g
at 4 °C for 15 min) to pellet magnetite-containing lysosomes.
To limit contamination by proteins nonspecifically sticking to
the Eppendorf microcentrifuge tube, the pellets were resus-
pended, combined in a final volume of 200 l of fractionation
Figure 5. Stat3-mediated regulation of the lysosomal compartment. A, validation by Western blot analysis of the lysosomal localization of flotillin 1 and
flotillin 2 using iron nanoparticles to isolate EpH4 lysosomes (Mag) after 72 h of OSM stimulation.White asterisk, indicates the expectedmolecular weight of
flotillin 2. Representative blots of n 3 (flotillin 1) and n 2 (flotillin 2) independent experiments are shown. B, microarray analysis of 12 different timepoints
during themammaryglandpregnancy cycle showing the involution-related expressionprofiles of flotillin 1 and flotillin 2.V, virgin;dG, days gestation;d L, days
lactation; h I, hours involution. C, fluorescencemicroscopy of LAMP1 and LAMP2 immunostaining in EpH4 cells treatedwithOSM for 72 h. Scale bars: 10m.D,
Westernblot analysis ofOSM-inducedchanges to the lysosomalproteins LAMP1, LAMP2,CD63, andcathepsinB inwhole-cell lysates fromnormal (WT) and two
independent Stat3 KO EpH4 cell lines after 72 h of stimulation. Proteinswere separated by SDS-PAGE under reducing or non-reducing conditions as indicated.
pro-Ctsb, pro formof cathepsin B; sc Ctsb, single-chain cathepsin B; Scram, scrambled sgRNA control EpH4 cells. E, microarray analysis of 12 different timepoints
during the mammary gland pregnancy cycle showing the involution-related expression profiles of CD63 and LAMP2.
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buffer, and transferred into a clean Eppendorf microcentrifuge
tube. The samples were then pelleted at 13,800 g for a further
15 min at 4 °C along with the PNS and SN samples.
Fractionation of purified lysosomes
To obtain “total” lysosomal lysates, whole lysosomes purified
as described above were incubated with 0.1% Triton X-100
(VWR International) for 10min on ice, vortexed intermittently
four times, and spun at 12,000 rpm (13,800  g at 4 °C for 15
min). The supernatant was transferred into new tubes. To sep-
arate the lysosomal content from the lysosomal membrane
fraction, the isolated lysosomes were resuspended in 5mMTris
buffer, pH 7.5, incubated on ice for 30 min or frozen in liquid
nitrogen, and then thawed at 37 °C five times. Lysosomal mem-
branes were pelleted by spinning at 15,000  g for 30 min at
4 °C. The supernatant (lysosomal content (LC)) was transferred
into a new tube. The pellet was resuspended in 50 l of 0.1%
TritonX-100 in PBS, incubated for 10min on ice, and intermit-
tently vortexed four times. After spinning at 17,000  g for 10
min at 4 °C, the supernatant (LM) was transferred into fresh
tubes.
Immunoblotting
PNS and SN samples were pelleted, resuspended in 50 l of
modified radioimmune precipitation assay buffer (50 mM Tris,
1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mMNaCl, 1
mM EGTA, and Complete protease inhibitor), and lysed on ice
for 30minwith intermittent vortexing. Sampleswere then spun
at 12,000 rpm (13,800 g at 4 °C for 15 min), and the superna-
tant was retained for Western blot analysis. Protein samples
(made up in modified radioimmune precipitation assay buffer
with 0.1% Triton X-100 or 5 mM Tris as described above) were
denatured and resolved on SDS-polyacrylamide gels. Proteins
were separated by SDS-PAGE under reducing conditions
unless stated otherwise. Immunoblotting was performed using
standard techniques, and antibody detection was achieved with
enhanced chemiluminescence reagent (ECL, GE Healthcare).
The following primary antibodies were used: rat anti-LAMP2
(ab13524, Abcam, 1:1,000), goat anti-cathepsin L (AF1515,
R&D Systems, 1:1,000), goat anti-cathepsin B (AF965, R&D
Systems, 1:1,000), mouse anti-COX IV (ab33985, Abcam,
1:1,000), rabbit anti-phosphatidylinositol 3-kinase, p85 (06-
496, Millipore, 1:1000), rabbit anti-Stat3 (sc-482, Santa Cruz
Biotechnology, 1:1000), rabbit anti-phospho-Stat3 (9131, Cell
Signaling, 1:1000), mouse anti-ERp57 (sc-23886, Santa Cruz
Biotechnology, 1:400), rabbit anti-GAPDH (5174, Cell Signal-
ing, 1:1000), goat anti-histone H3 (sc-8654, Santa Cruz Bio-
technology, 1:1000), rabbit anti-Rab5 (2143, Cell Signaling,
1:1000), rat anti-LAMP1 (ID4B, Developmental Studies
Hybridoma Bank, 1:200), rat anti-CD63 (NVG-2, 143901, Bio-
legend, 1:1000), rabbit anti-flotillin 1 (18634, Cell Signaling
Technology, 1:800), and rabbit anti-flotillin 2 (HPA0013961,
Atlas Antibodies, 1:200). All horseradish peroxidase-conju-
gated secondary antibodies were from Dako.
Cathepsin activity assay
10 l of lysate was added to a total of 200 l of cathepsin
reaction buffer (50 mM sodium acetate, 8 mM EDTA, 8 mM
dithiothreitol, and 1 mM Pefabloc subcellular fractionation
buffer at pH 6). Cathepsin B and L activity was measured with
the fluorescent substrate Z-Phe-Arg-AMC (50 M, Merk Mil-
lipore) in a Synergy HT multi-detection microplate reader
(excitation 380 nM and emission 442 nM, BioTek). Fluorescence
was measured immediately every minute for 1 h at 37 °C. The
initial rates of cathepsin B and L activity were determined from
the linear part of the resulting curve and normalized to total
cathepsin activity obtained from Triton X-100–extracted
lysates. Cathepsin activity reaction buffer alone or containing
50 M Z-Phe-Arg-AMC served as the control. The assay was
performed in duplicate or triplicate per condition in a 96-well
flat-bottom microtiter plate (Thermo Scientific).
-Glucuronidase assay
10 l of lysate was added to 125 l of sodium acetate/acetic
acid buffer (0.1 M sodium acetate and 0.1 M acetic acid, pH 4.8)
containing 10 mM of the fluorescent substrate 4-methylumbel-
liferone--D-glucuronide (4-MU-Glu, Biosynth) on ice. Sam-
ples were incubated for 30 min at 37 °C, and the reaction was
stopped subsequently by the addition of 100 l of glycine/car-
bonate buffer (0.17 M glycine and 0.17 M sodium carbonate, pH
9.8) on ice. Fluorescence was measured in a Synergy HTmulti-
detection microplate reader (excitation 380 nM and emission
442 nM, BioTek). Sodium acetate/acetic acid buffer alone or
containing 10 mM 4-MU-Glu served as the control. The assay
was performed in duplicate or triplicate per condition in a
96-well flat-bottom microtiter plate (Thermo Scientific).
FITC-dextran andMitoTracker staining of lysosomal
preparations
EpH4 cells were seeded at a density of 3 106 in 15-cmNunc
cell culture dishes (Thermo Scientific). Plates were labeled for
2 h with 2.5 mg/ml 10-kDa FITC-dextran (Sigma) in 10%
DMEM containing 10% ferrofluid in BSA/PBS () or in FITC-
dextran–containing medium only (minus iron nanoparticles
()). Cells were washed three times in PBS followed by a 2-h
chase period in 10% DMEM prior to labeling of the mitochon-
dria with 500 nM MitoTracker (MitoTracker Red FM, Invitro-
gen) in 10% DMEM for 30 min. Plates were then washed three
times in PBS, and the cells were scraped into 500 l of PBS and
spun at 900 g for 3 min at 4 °C. Cell pellets were resuspended
in 700 l of fractionation buffer containing Complete protease
inhibitors and homogenized with five strokes in a Dounce
homogenizer. To obtain the PNS, the homogenate was spun at
800 g for 10 min at 4 °C. The PNS was transferred into a new
tube, and 50 l was retained for analysis (PNS/). The PNS
was incubated on a magnetic rack for 1 h at 4 °C on a rocker.
Post-incubation SN was removed, and 50 l was kept for anal-
ysis (SN/). The tubes were washed three times with 1 ml of
cold fractionation buffer on the magnetic rack. Following the
last wash, the tubes were removed and spun at 13,800 g for 15
min at 4 °C. The lysosomal pellet (LP/) was resuspended in
25 l of fractionation buffer. 10 l of the magnetic nanopar-
ticle-labeled and unlabeled PNS, SN, and lysosomal pellets was
mixed with 10 l of PBS/glycerol (v/v 50:50), dropped onto a
microscope slide, and covered by a coverslip for imaging using
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a Zeiss Axioplan 2microscope and a Plan-Apochromat 63x/1.4
oil objective (Zeiss).
Immunofluorescence and LysoTracker Red staining
EpH4 cells were seeded on glass coverslips or ibidi 35-mm
glass-bottom dishes and stimulated with OSM as described
above. After OSM stimulation cells were fixed with 4% parafor-
maldehyde for 5 min at 37 °C and subsequently permeabilized
with 0.5% v/v TritonX-100 in PBS for 10 min at room temper-
ature. Cells were blocked in 10% normal goat serum (Sigma) in
PBS for 1 h at room temperature and then incubated with pri-
mary antibody in PBS for 1 h at room temperature or overnight
at 4 °C. Primary antibodies used were rat anti-LAMP2 (GL2A7,
ab13524, Abcam, 1:200), rat anti-LAMP1 (ID4B, Develop-
mental Studies Hybridoma Bank, 1:200), and rabbit anti-flo-
tillin 2 (HPA0013961, Atlas Antibodies, 1:200). Cells were then
washed in PBS followed by secondary antibody staining (Cy3
goat anti-rat IgG, Life Technologies, 1:500; Alexa Fluor-488
goat anti-rabbit IgG, Invitrogen, A11008, 1:500; or Alexa Flu-
or-647 goat anti-rat IgG, Life Technologies, A21247, 1:500) for
1 h at room temperature. Nuclei were counterstained with
Hoechst 33342 (Sigma Aldrich, 1:1000). Cells were stained
with LysoTracker Red DND-99 (Life Technologies) at 1:10,000
for 30 min at room temperature according to the manufactu-
rer’s instructions. Images were acquired using a Zeiss Axioplan
2 microscope (Zeiss, Jena, Germany) or a Leica TCS SP8
inverted confocal microscope. Image reconstructions were
generated using ImageJ (version 1.50c, National Institutes of
Health) (63).
Transmission electionmicroscopy
EpH4 cell lysosomes were isolated using the magnetic nano-
particle protocol and adsorbed to a TEM grid, followed by two
wash steps in H2O to remove any remaining buffer salts. Sam-
ples were either imaged directly using a Tecnai G2 electron
microscope or negatively stained with 1% uranyl acetate
beforehand.
Silver staining of protein gels
Protein samples were run on 4–15%Mini-Protean TGX gels
(Bio-Rad) and fixed in 45% methanol, 1% v/v, in ddH2O for 30
min. After washing in ddH2O, the gels were sensitized with
0.02% sodium thiosulfate (Na2S2O3) for 1 min and rinsed in
ddH2O three times for 20 s. Next the gels were stained in
ddH2Ocontaining 0.2% silver nitrate (AgNO3) and 0.02% form-
aldehyde for 20min. This was followed by rinsing the gels twice
in ddH2O for 20 s and developing them for 3 min in 3% sodium
carbonate (Na2CO3), 0.0005% sodium thiosulfate, 0.05% form-
aldehyde in ddH2O. The developed gels were rinsed twice in
ddH2O for 20 s and blocked in 5% acetic acid.
Mass-spectrometrymethods
AllMS experiments were undertaken at the Cambridge Cen-
tre for Proteomics (University of Cambridge). For all experi-
ments submitted for MS analysis, a corresponding unlabeled
(no magnetic particles) control sample was also analyzed. For
the OSM-related experiments, three independent biological
repeats (three OSM and corresponding vehicle control sam-
ples) were performed, and a corresponding unlabeled (nomag-
neticparticles) control sample alsowas submitted for each inde-
pendent replicate.
Silver destaining and tryptic digest
After 1D gel electrophoresis, gel pieces were cut into
1–2–mm cubes and placed into 0.5-ml tubes. The gel pieces
were incubated with 100 l of silver-destaining solution (a 1:1
ratio of 27 mM potassium ferricyanide (K3[Fe(CN)6]) and 100
mM sodium thiosulphate (Na2S2O3) in high-performance liq-
uid chromatography (HPLC) grade water) for 10 min at 37 °C.
This step was repeated with fresh destaining solution until
complete clarification of the gel pieces was obtained. Subse-
quently, the pieces were washed in HPLC-grade water prior to
incubation in 100% acetonitrile at 37 °C until they appeared
white and shrunken. The acetonitrile was removed, and any
residual solution was evaporated by incubation at 37 °C for 10
min. To reduce the proteins, the gel pieces were incubated in 50
l of 10 mM DTTmade up in 100 mM ammonium bicarbonate
(NH4HCO3) at 56 °C for 1 h. For alkylation 50 l of 55 mM
iodoacetamide (C2H4INO) made up in 100 mM ammonium
bicarbonate was then added, and the gel pieces were incubated
at room temperature in the dark for 45 min. The liquid was
removed, 100l of 100mM ammoniumbicarbonate was added,
and the gel pieces were incubated at 37 °C for 10 min. After
removing the liquid, the gel pieces were incubated in 50% ace-
tonitrile (C2H3N) in 100 mM ammonium bicarbonate at 37 °C
for 10min, whichwas then replaced by 100l 100% acetonitrile
to dry the gel pieces. To evaporate the acetonitrile, the gel
pieces were incubated further at 37 °C, ensuring that they were
completely dry prior to tryptic digest. 50–60l of trypsin solu-
tion (10 ng/l in 50 mM ammonium bicarbonate) was added to
the gel pieces, and they were incubated overnight.
LC-MS/MS analysis
After tryptic digestion, the supernatant was pipetted into a
sample vial and loaded onto an autosampler for automated
LC-MS/MS analysis. The pilot LC-MS/MS experiment was
performed using a Dionex Ultimate 3000 RSLC nanoUPLC
(Thermo Fisher Scientific Inc., Waltham, MA) system and a Q
Exactive Orbitrap mass spectrometer (Thermo Fisher Scien-
tific). All OSM-related and deglycosylation experiments were
performed using aWaters NanoAcquity UPLC (Thermo Fisher
Scientific) system and an Orbitrap Velos mass spectrometer
(Thermo Fisher Scientific). For the pilot experiment using the
Q Exactive mass spectrometer, separation of the peptides was
performed by reverse-phase chromatography at a flow rate of
300 nl/min and a reverse-phase nano EASY-Spray column
(Thermo Scientific PepMap C18, 2-m particle size, 100-Å
pore size, 75-m i.d.  50-cm length). Peptides were loaded
onto a pre-column (Thermo Scientific PepMap 100 C18, 5-m
particle size, 100-Åpore size, 300-mi.d. 5-mm length) from
the Ultimate 3000 autosampler with 0.1% formic acid for 3 min
at a flow rate of 10 l/min. After this time period, the column
valve was switched to allow elution of peptides from the pre-
column onto the analytical column. Solvent A consisted of
water  0.1% formic acid and solvent B consisted of 80% ace-
tonitrile and 20%water 0.1% formic acid. The linear gradient
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employed was 2–40% B in 30 min. The LC eluant was sprayed
into the mass spectrometer by means of an EASY-Spray source
(Thermo Fisher Scientific). All m/z values of eluting ions were
measured in an Orbitrap mass analyzer set at a resolution of
70,000. Data-dependent scans (top 20) were employed to auto-
matically isolate and generate fragment ions by higher-energy
collisional dissociation (HCD) in the quadrupolemass analyzer,
andmeasurement of the resulting fragment ionswas performed
in the Orbitrap analyzer set at a resolution of 17,500. Peptide
ions with charge states of 2 and above were selected for
fragmentation.
For the nanoAcquity/Orbitrap Velos experiments, separa-
tion of the peptides was performed by reverse-phase chroma-
tography using a Waters reverse-phase nano column (BEH
C18, 75-m i.d. 250 mm, 1.7-m particle size) at a flow rate
of 300 nl/min. The peptides were initially loaded onto a pre-
column (Waters UPLC Trap Symmetry C18, 180-m i.d. 20
mm, 5-m particle size) from the nanoAcquity sample man-
ager with 0.1% formic acid for 3 min at a flow rate of 10l/min.
After this period, the column valve was switched to allow the
elution of peptides from the pre-column onto the analytical
column. Solvent A was water 0.1% formic acid and solvent B
was acetonitrile  0.1% formic acid. The linear gradient
employedwas 3–40%B in 40min (60min total run time includ-
ing wash and equilibration steps).
The LC eluant was sprayed into the mass spectrometer by
means of a standard Thermo Scientific nanospray source. All
m/z values of eluting ions were measured in the Orbitrap Velos
mass analyzer set at a resolution of 30,000. Data-dependent
scans (top 20) were employed to automatically isolate and gen-
erate fragment ions by collision-induced dissociation in the lin-
ear ion trap, resulting in the generation ofMS/MS spectra. Ions
with charge states of 2 and above were selected for fragmen-
tation. Post-run, all data were processed using Protein Discov-
erer (version 2.1, ThermoFisher).
All LC-MS/MS data generated from the pilot experiment,
and deglycosylation experiments were converted to mgf files.
These files were then submitted to theMascot search algorithm
(Matrix Science, London, UK) and searched against the Uni-
Prot mouse database (UniProt_Mouse_Oct13 10090_Oct2013
82208 sequences; 36,313,543 residues) using a fixed modifica-
tion of carbamidomethyl (C) and variable modifications of oxi-
dation (M) and deamidation (NQ). Peptide identifications were
accepted if they could be established at greater than 95.0%
probability.
For analysis of OSM-related experiments, all MS/MS data
were converted tomgf files and submitted to theMascot search
algorithm (Matrix Science) and searched against the swis-
sprot_2013_11 database (with a mouse taxonomy filter; 16,693
sequences). Mascot was searched with a fragment ionmass tol-
erance of 0.80 Da and a parent ion tolerance of 25 ppm. Trypsin
was specified as the enzyme, and carbamidomethyl of cysteine
was specified inMascot as a fixedmodification. Deamidation of
asparagine and glutamine and oxidation of methionine were
specified inMascot as variable modifications. For protein iden-
tification, Scaffold (version Scaffold_4.7.2, Proteome Software
Inc., Portland, OR) was used to validateMS/MS–based peptide
and protein identifications. Peptide identifications were
accepted if they could be established at greater than 95.0%
probability by the Scaffold Local FDR algorithm. Protein iden-
tifications were accepted if they could be established at greater
than 99.0% probability to achieve an FDR less than 5.0% and
contained at least three identified peptides. Protein probabili-
ties were assigned by the Protein Prophet algorithm (64).
Proteins that contained similar peptides and could not be dif-
ferentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony. To estimate OSM-induced
changes in protein abundance, the emPAI values of OSM and
vehicle-treated samples were compared (65). emPAI provides
an approximate and relative quantitation of the proteins in a
mixture based on protein coverage by the peptide matches in a
database search result. This method takes into account the fact
that the more observed peptides will be generated for larger
proteins and for proteins that have many peptides in the pre-
ferredmass range formass spectrometry (65). Although emPAI
and other similar spectral countingmethods provide only semi-
quantitative information, they are highly correlated to protein
abundance (65). EmPAI values were calculated in Scaffold, ver-
sion 4.7.2, in addition to all comparative analyses of OSM and
vehicle-treated samples and associated statistics.
Deglycosylation of lysosomal proteins
Onel of 10 glycoprotein denaturing buffer (New England
Biolabs) was added to 9 l of lysosomal membrane proteins.
The glycoproteins were denatured by heating to 95 °C for 10
min. Subsequently, 2 l of 10 G7 reaction buffer (New Eng-
land Biolabs), 2l of 10%Nonidet P-40 (New England Biolabs),
and 1 l of PNGase F (New England Biolabs) were added, and
the reaction volume was made up to 20 l with H2O. The reac-
tion mix was incubated at 37 °C for 30 min. The deglycosylated
protein samples were used for MS analysis or made up in 4
sample buffer and analyzed by Western blotting.
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